- GAAP diluted EPS of $3.04 - Pro Forma diluted EPS of $3.35 - GAAP
operating margin of 62 percent - Pro forma operating margin of 63
percent CHICAGO, Oct. 29 /PRNewswire-FirstCall/ -- CME Group Inc.
(NASDAQ:CME) today reported that third-quarter GAAP total revenues
were $650 million, and GAAP operating income was $401 million from
the third quarter of 2008. Third-quarter net income on a GAAP basis
was $202 million and diluted earnings per share on a GAAP basis
were $3.04. The 2009 GAAP results reflect the operations of Chicago
Mercantile Exchange (CME), Board of Trade of the City of Chicago
(CBOT), and New York Mercantile Exchange (NYMEX) and include
reductions in net income of $21 million, consisting of an
impairment charge on our investment in IMAREX of $19 million and
merger-related items of $2 million. The charge for IMAREX, a
Norwegian-based freight and energy exchange and interdealer broker,
was due to a decline in IMAREX fair value relative to the fair
value established at the time of CME Group's acquisition of NYMEX
in August 2008. The 2008 GAAP results reflect the operations of
both CME and CBOT, as well as the results of NYMEX after August 22,
2008, when the acquisition closed. Third-quarter pro forma non-GAAP
diluted earnings per share were $3.35, down 19 percent compared
with the prior-year period. All pro forma results reflect the
operations of both CME Group and NYMEX as if they were combined for
all periods reported, and third-quarter 2009 pro forma non-GAAP
results exclude the impairment charge and merger-related items
mentioned above. Total pro forma revenues decreased 17 percent from
the prior year to $650 million and increased $2.6 million from
second-quarter 2009 revenues. Pro forma operating expenses
decreased 10 percent to $244 million, compared with the same period
last year. Third-quarter pro forma operating income was $407
million, a decrease of 21 percent from $515 million for the
year-ago period. The company's significant focus on expense
management during ongoing challenging market conditions helped
drive a strong pro forma operating margin of 63 percent, in line
with second-quarter 2009 operating margin, and down from 65 percent
from the same period a year ago. Operating margin is defined as
operating income as a percentage of total revenues. Third-quarter
2009 pro forma net income decreased 20 percent to $223 million,
compared with third-quarter 2008. All references to volume and rate
per contract information in the text of this document exclude our
non-traditional TRAKRS products, for which CME Group receives
significantly lower clearing fees than other CME Group products,
Swapstream, and HuRLO products. Pro forma measures do not replace
and are not a substitute for GAAP financial results. They are
provided to improve overall understanding of current financial
performance and to provide a meaningful comparison with prior
periods. A full reconciliation of third-quarter and
first-nine-months 2009 pro forma results to GAAP results is
included with the attached financial statements. "Building on solid
third-quarter results, October has been a strong volume month,
particularly in foreign exchange and energy," said CME Group
Executive Chairman Terry Duffy. "As the economy continues to
stabilize, there is room for further organic growth in our core
business. At the same time, we are actively working to ensure that
the benefits our business model brings to the financial system are
communicated to the legislators and regulators who are charged with
regulatory reform." "As part of our global growth strategy, we have
continued to invest in enhancing our global marketing and sales
staff and expanding our CME ClearPort OTC clearing services across
all asset classes," said CME Chief Executive Officer Craig Donohue.
"During the quarter we also announced a partnership with Bursa
Malaysia to extend our ability to deliver products and services to
Asian customers. The strength of our core business and our capacity
to deliver high quality, cleared-only offerings, coupled with
strategic partnerships around the globe, such as Bursa Malaysia and
BM&F Bovespa, position CME Group to compete effectively where,
when, and how our customers want." CME Group Inc. Third-Quarter
2009 Results Financial Highlights: GAAP ($s in millions, except per
share) Q3 FY09 Q3 FY08 Y/Y YTD FY09 YTD FY08 Y/Y ------- -------
--- -------- -------- --- Revenues $650 $681 -4% $1,945 $1,869 4%
Expenses $249 $260 -4% $759 $705 8% Operating Income $401 $421 -5%
$1,187 $1,164 2% Operating Margin % 61.7% 61.8% 61.0% 62.3% Net
Income $202 $169 20% $623 $653 -5% Diluted EPS $3.04 $2.81 8% $9.37
$11.61 -19% Pro Forma Non-GAAP ($s in millions, except per share)
Q3 FY09 Q3 FY08 Y/Y YTD FY09 YTD FY08 Y/Y ------- ------- ---
-------- -------- --- Revenues $650 $787 -17% $1,945 $2,360 -18%
Expenses $244 $272 -10% $739 $827 -11% Operating Income $407 $515
-21% $1,206 $1,532 -21% Operating Margin % 62.5% 65.5% 62.0% 64.9%
Net Income $223 $278 -20% $660 $844 -22% Diluted EPS $3.35 $4.13
-19% $9.92 $12.59 -21% NOTE: See the CME Group Inc. Reconciliation
of GAAP to Pro Forma Non-GAAP Measures for detail related to the
adjustments made to reach the pro forma results. Third-quarter 2009
average daily volume was 10.1 million contracts, down 23 percent
compared with third-quarter 2008. Pro forma clearing and
transaction fee revenue was $541 million, down from $665 million in
third-quarter 2008, but up one percent from second-quarter 2009.
The total pro forma average rate per contract for CME Group
increased six percent from third-quarter 2008 to 83 cents, and
increased one percent compared with 82 cents in second-quarter
2009. Quotation data fees were down 11 percent to $81 million in
the third quarter due primarily to a decrease in screen counts
associated with cost-cutting initiatives at customer firms.
Third-quarter 2009 pro forma non-operating expense was $26 million,
driven primarily by interest expense and borrowing costs of $32
million related to the NYMEX acquisition, which was partially
offset by $8 million of investment income. Additionally, the
third-quarter 2009 effective tax rate was 41.4 percent, down from
43.3 percent in third-quarter 2008. As of September 30, the company
had $298 million of cash and marketable securities and $2.5 billion
of debt. During the quarter, the company paid down approximately
$450 million of debt. CME Group will hold a conference call to
discuss third-quarter 2009 results at 8:30 a.m. Eastern Time today.
A live audio Webcast of the call will be available on the Investor
Relations section of CME Group's Web site at
http://www.cmegroup.com/. An archived recording will be available
for up to two months after the call. CME Group
(http://www.cmegroup.com/) is the world's largest and most diverse
derivatives marketplace. Building on the heritage of CME, CBOT and
NYMEX, CME Group serves the risk management needs of customers
around the globe. As an international marketplace, CME Group brings
buyers and sellers together on the CME Globex electronic trading
platform and on trading floors in Chicago and New York. By acting
as the buyer to every seller and the seller to every buyer, CME
Clearing virtually eliminates counterparty credit risk. CME
Clearing also offers financial safeguards to help mitigate systemic
risk, providing the security and confidence market participants
need to operate, invest and grow. CME Group offers the widest range
of benchmark products available across all major asset classes,
including futures and options based on interest rates, equity
indexes, foreign exchange, energy, agricultural commodities,
metals, and alternative investment products such as weather and
real estate. CME Group is listed on NASDAQ under the symbol "CME."
The Globe logo, CME, Chicago Mercantile Exchange, CME Group,
Globex, E-mini and CME ClearPort are trademarks of Chicago
Mercantile Exchange Inc. CBOT and Chicago Board of Trade, Inc. are
trademarks of the Board of Trade of the City of Chicago. NYMEX and
New York Mercantile Exchange are trademarks of New York Mercantile
Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All
other trademarks are the property of their respective owners.
Further information about CME Group (NASDAQ:CME) and its products
can be found at http://www.cmegroup.com/. Statements in this press
release that are not historical facts are forward-looking
statements. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that
are difficult to predict. Therefore, actual outcomes and results
may differ materially from what is expressed or implied in any
forward-looking statements. Among the factors that might affect our
performance are: our ability to realize the benefits and control
the costs of our merger with NYMEX Holdings, Inc. and our ability
to successfully integrate the businesses of CME Group and NYMEX
Holdings, including the fact that such integration may be more
difficult, time consuming or costly than expected and revenues
following the merger may be lower than expected and expected cost
savings from the merger may not be fully realized within the
expected time frames or at all; increasing competition by foreign
and domestic entities, including increased competition from new
entrants into our markets and consolidation of existing entities;
our ability to keep pace with rapid technological developments,
including our ability to complete the development and
implementation of the enhanced functionality required by our
customers; our ability to continue introducing competitive new
products and services on a timely, cost-effective basis, including
through our electronic trading capabilities, and our ability to
maintain the competitiveness of our existing products and services;
our ability to adjust our fixed costs and expenses if our revenues
decline; our ability to continue to generate revenues from our
processing services; our ability to maintain existing customers,
develop strategic relationships and attract new customers; our
ability to expand and offer our products in foreign jurisdictions;
changes in domestic and foreign regulations; changes in government
policy, including policies relating to common or directed clearing,
changes as a result of a harmonization of the regulation of the
Securities and Exchange Commission and the U.S. Commodity Futures
Trading Commission, or changes relating to the recently enacted or
proposed legislation relating to the current economic crisis; the
costs associated with protecting our intellectual property rights
and our ability to operate our business without violating the
intellectual property rights of others; our ability to generate
revenue from our market data that may be reduced or eliminated by
the growth of electronic trading or declines in subscriptions;
changes in our rate per contract due to shifts in the mix of the
products traded, the trading venue and the mix of customers
(whether the customer receives member or non-member fees or
participates in one of our various incentive programs) and the
impact of our tiered pricing structure; the ability of our
financial safeguards package to adequately protect us from the
credit risks of clearing members; the ability of our compliance and
risk management methods to effectively monitor and manage our
risks; changes in price levels and volatility in the derivatives
markets and in underlying fixed income, equity, foreign exchange
and commodities markets; economic, political and market conditions,
including the recent volatility of the capital and credit markets
and the impact of current economic conditions on the trading
activity of our current and potential customers; our ability to
accommodate increases in trading volume and order transaction
traffic without failure or degradation of performance of our
systems; our ability to execute our growth strategy and maintain
our growth effectively; our ability to manage the risks and control
the costs associated with our acquisition, investment and alliance
strategy; our ability to continue to generate funds and/or manage
our indebtedness to allow us to continue to invest in our business;
industry and customer consolidation; decreases in trading and
clearing activity; the imposition of a transaction tax on futures
and options on futures transactions; the unfavorable resolution of
material legal proceedings, the seasonality of the futures
business; and changes in the regulation of our industry with
respect to speculative trading in commodity interests and
derivatives contracts. More detailed information about factors that
may affect our performance may be found in our filings with the
Securities and Exchange Commission, including our most recent
periodic reports filed on Form 10-K and Form 10-Q, which are
available in the Investor Relations section of the CME Group Web
site. We undertake no obligation to publicly update any
forward-looking statements, whether as a result of new information,
future events or otherwise. CME-E CME Group Inc. and Subsidiaries
Consolidated Balance Sheets (in millions) September 30, December
31, 2009 2008 ---- ---- ASSETS Current Assets: Cash and cash
equivalents $204.1 $297.9 Collateral from securities lending -
426.9 Marketable securities, including pledged securities 93.7
310.1 Accounts receivable, net of allowance 264.0 234.0 Other
current assets 119.6 189.1 Cash performance bonds and security
deposits 6,824.8 17,653.5 ------- -------- Total current assets
7,506.2 19,111.5 Property, net of accumulated depreciation and
amortization 726.9 707.2 Intangible assets - trading products
16,982.0 16,982.0 Intangible assets - other, net of accumulated
amortization 3,277.1 3,369.4 Goodwill 7,549.3 7,519.2 Other assets
478.1 469.4 ----- ----- Total Assets $36,519.6 $48,158.7 =========
========= LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities:
Accounts payable $36.1 $71.0 Payable under securities lending
agreements - 456.8 Short-term debt 299.7 249.9 Other current
liabilities 157.8 211.8 Cash performance bonds and security
deposits 6,824.8 17,653.5 ------- -------- Total current
liabilities 7,318.4 18,643.0 Long-term debt 2,239.3 2,966.1
Deferred tax liabilities 7,669.9 7,728.3 Other liabilities 161.7
132.7 ----- ----- Total Liabilities 17,389.3 29,470.1 Shareholders'
equity 19,130.3 18,688.6 -------- -------- Total Liabilities and
Shareholders' Equity $36,519.6 $48,158.7 ========= ========= CME
Group Inc. and Subsidiaries Consolidated Statements of Income
(dollars in millions, except per share amounts; shares in
thousands) Quarter Ended Nine Months Ended September 30, September
30, 2009 2008 2009 2008 ---- ---- ---- ---- Revenues Clearing and
transaction fees $540.6 $558.7 $1,605.2 $1,542.3 Quotation data
fees 81.4 75.7 249.0 192.3 Processing services 0.1 17.9 0.3 53.9
Access and communication fees 11.4 10.9 34.5 32.2 Other 16.9 17.7
56.3 48.5 ---- ---- ---- ---- Total Revenues 650.4 680.9 1,945.3
1,869.2 Expenses Compensation and benefits 87.3 84.5 262.0 231.4
Communications 11.5 11.5 35.5 39.1 Technology support services 11.3
11.9 34.7 47.0 Professional fees and outside services 17.9 17.0
61.9 47.8 Amortization of purchased intangibles 30.7 29.1 94.5 63.2
Depreciation and amortization 32.3 34.1 93.4 102.9 Occupancy and
building operations 19.1 18.9 57.3 52.9 Licensing and other fee
agreements 21.2 19.3 67.5 44.8 Restructuring 0.6 0.1 5.2 2.1 Other
17.1 33.8 46.7 73.7 ---- ---- ---- ---- Total Expenses 249.0 260.2
758.7 704.9 Operating Income 401.4 420.7 1,186.6 1,164.3
Non-Operating Income and Expense Investment income 10.5 18.0 22.4
41.4 Impairment of long-term investment (22.4) - (22.4) - Gains
(losses) on derivative investments - 7.4 - (7.8) Securities lending
interest income - 8.6 2.8 32.2 Securities lending interest and
other costs - (28.9) (0.1) (48.2) Interest and other borrowing
costs (32.1) (17.9) (103.2) (21.6) Guarantee of exercise right
privileges - 8.0 - 12.8 Equity in losses of unconsolidated
subsidiaries (1.6) (20.0) (4.5) (27.9) Other income (expense) - 0.1
(0.4) (8.4) --- --- ---- ---- Total Non-Operating (45.6) (24.7)
(105.4) (27.5) Income Before Income Taxes 355.8 396.0 1,081.2
1,136.8 Income tax provision (153.5) (227.3) (458.0) (483.4) ------
------ ------ ------ Net Income $202.3 $168.7 $623.2 $653.4 ======
====== ====== ====== Earnings per Common Share: Basic $3.05 $2.82
$9.39 $11.66 Diluted 3.04 2.81 9.37 11.61 Weighted Average Number
of Common Shares: Basic 66,384 59,870 66,339 56,054 Diluted 66,573
60,086 66,514 56,302 CME Group Inc. and Subsidiaries Pro Forma
Non-GAAP Consolidated Statements of Income (dollars in millions,
except per share amounts; shares in thousands) Quarter Ended Nine
Months Ended September 30, September 30, 2009 2008 2009 2008 ----
---- ---- ---- Revenues Clearing and transaction fees $540.6 $665.2
$1,605.2 $2,008.2 Quotation data fees 81.4 91.6 249.0 261.4
Processing services 0.1 0.6 0.3 1.6 Access and communication fees
11.4 11.1 34.5 33.0 Other 16.9 18.3 56.3 55.6 ---- ---- ---- ----
Total Revenues 650.4 786.8 1,945.3 2,359.8 Expenses Compensation
and benefits 84.5 93.4 257.9 277.5 Communications 11.5 12.1 35.5
42.3 Technology support services 11.3 13.1 34.7 52.6 Professional
fees and outside services 16.4 18.4 56.2 56.2 Amortization of
purchased intangibles 30.5 31.3 91.4 92.4 Depreciation and
amortization 32.3 34.8 93.4 105.5 Occupancy and building operations
19.1 21.2 57.3 63.9 Licensing and other fee agreements 21.2 25.2
67.5 70.7 Other 16.8 22.3 45.5 66.3 ---- ---- ---- ---- Total
Expenses 243.6 271.8 739.4 827.4 Operating Income 406.8 515.0
1,205.9 1,532.4 Non-Operating Income and Expense Investment income
7.7 22.4 18.3 54.7 Gains (losses) on derivative investments - 0.1 -
0.2 Securities lending interest income - 10.5 2.8 46.7 Securities
lending interest and other costs - (15.0) (0.1) (44.7) Interest and
other borrowing costs (32.1) (38.1) (103.2) (114.3) Equity in
losses of unconsolidated subsidiaries (1.6) (5.1) (4.5) (17.2) ----
---- ---- ----- Total Non-Operating (26.0) (25.2) (86.7) (74.6)
Income Before Income Taxes 380.8 489.8 1,119.2 1,457.8 Income tax
provision (157.8) (212.0) (459.3) (613.7) ------ ------ ------
------ Net Income $223.0 $277.8 $659.9 $844.1 ====== ====== ======
====== Earnings per Diluted Common Share $3.35 $4.13 $9.92 $12.59
Weighted Average Number of Diluted Common Shares(1) 66,573 67,325
66,514 67,062 Note: All pro forma results for CME Group assume the
acquisition of NYMEX was completed as of the beginning of the
period presented. See CME Group Inc. Reconciliation of GAAP to Pro
Forma Non-GAAP Measures for detail on all of the adjustments made
to reach the pro forma results. (1) Weighted average number of
diluted common shares includes merger-related shares converted or
issued for the entire period reported. CME Group Inc. and
Subsidiaries Reconciliation of GAAP to Pro Forma Non-GAAP Measures
(in millions) Quarter Ended Nine Months Ended September 30,
September 30, 2009 2008 2009 2008 ---- ---- ---- ---- GAAP Results
Revenues $650.4 $680.9 $1,945.3 $1,869.2 Expenses 249.0 260.2 758.7
704.9 ----- ----- ----- ----- Operating income 401.4 420.7 1,186.6
1,164.3 Non-operating income and expense (45.6) (24.7) (105.4)
(27.5) ----- ----- ------ ----- Income before income taxes 355.8
396.0 1,081.2 1,136.8 Income tax provision (153.5) (227.3) (458.0)
(483.4) ------ ------ ------ ------ Net Income $202.3 $168.7 $623.2
$653.4 ====== ====== ====== ====== Pro Forma Adjustments Revenues:
NYMEX pre-merger revenue $- $124.3 $- $544.0 Intercompany revenue
elimination(1) - (10.7) - (45.7) FXMarketSpace write down - (7.7) -
(7.7) --- ---- --- ---- Total Pro Forma Revenue Adjustment - 105.9
- 490.6 Expenses: NYMEX pre-merger expense - 81.5 - 229.2
Intercompany expense elimination (1) - (10.8) - (45.8) Deferred
compensation gain/loss reclass(2) (2.8) 2.9 (4.1) 4.5 Swapstream
write down (0.3) (14.3) (0.3) (14.3) Amortization of intangibles
(3) - 5.6 (2.8) 32.6 Depreciation adjustment from building life
change (4) - 1.0 - 4.0 Loss on sale of metals - (2.8) - (2.8)
FXMarketSpace write down - (2.6) - (2.6) Other (5) (2.3) (48.9)
(12.1) (82.3) ---- ----- ----- ----- Total Pro Forma Expense
Adjustment (5.4) 11.6 (19.3) 122.5 ---- ---- ----- ----- Adjustment
to operating income 5.4 94.3 19.3 368.1 Non-operating income and
expense: NYMEX premerger non-operating income - (0.3) - 32.4
Interest on debt acquired for NYMEX deal - (19.3) - (88.6) Deferred
compensation gain/loss reclass(2) (2.8) 2.9 (4.1) 4.5 Equity
investment unusual gain/ loss(6) - 15.9 - (14.7) Securities lending
writedown - 15.7 - 15.7 ERP Guarantee (7) - (8.0) - (12.8) BM&F
Bovespa (8) - (7.4) - 16.4 Green Exchange(9) - - 0.4 - IMAREX
impairment 22.4 - 22.4 - ---- --- ---- --- Total Pro Forma
Non-Operating Income and Expense Adjustment 19.6 (0.5) 18.7 (47.1)
---- ---- ---- ----- Adjustment to income before income taxes 25.0
93.8 38.0 321.0 Adjustment to income tax provision (4.3) 15.3 (1.3)
(130.3) ---- ---- ---- ------ Adjustment to net income $20.7 109.1
$36.7 $190.7 ===== ===== ===== ====== Pro Forma Non-GAAP Results
Revenues 650.4 786.8 1,945.3 2,359.8 Expenses 243.6 271.8 739.4
827.4 ------ ------ ------ ------ Operating income 406.8 515.0
1,205.9 1,532.4 Non-operating income and expense (26.0) (25.2)
(86.7) (74.6) ----- ------ ----- ----- Income before income taxes
380.8 489.8 1,119.2 1,457.8 Income tax provision(10) (157.8)
(212.0) (459.3) (613.7) ------ ------- ------ ------ Net Income
$223.0 $277.8 $659.9 $844.1 ===== ====== ===== ===== Notes: (1)
Eliminate processing services provided prior to the NYMEX
acquisition. (2) Remove gains and losses related to a deferred
compensation plan that are recorded in compensation with a
corresponding offset in investment income. (3) Add amortization of
intangible assets recorded in purchase of NYMEX. (4) Adjust
depreciation for changes in value and useful life of building
acquired from NYMEX. (5) Reverse effect of restructuring,
accelerated depreciation, integraton and legal expenses related to
the merger with CBOT and the acquisition of NYMEX. Also removes
other merger-related transaction costs that were expensed and
transaction costs related to the acquisition of CMA. (6) Write-down
of Optionable as well as a gain related to TSX Group. (7) Reverse
impact of exercise right privilege guarantee. (8) Reverse
derivative gains/losses and transaction costs related to the
BM&F/Bovespa investment. (9) Reverse transaction costs related
to the investment in Green Exchange. (10) Pro forma adjustments are
tax effected at CME Group's estimated statutory tax rate. CME Group
Inc. Quarterly Operating Statistics 3Q 2008 4Q 2008 1Q 2009 2Q 2009
3Q 2009 ------- ------- ------- ------- ------- Trading Days 64 64
61 63 64 Quarterly Average Daily Volume (ADV) CME Group ADV (Legacy
CME, CBOT, NYMEX and COMEX combined, in thousands) Product Line 3Q
2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009 ------------ ------- -------
------- ------- ------- Interest rates 6,030 3,692 3,843 4,389
4,422 Equities 3,842 3,993 3,537 2,988 2,656 Foreign exchange 710
481 507 568 660 Energy (including ClearPort) 1,475 1,290 1,524
1,396 1,484 Commodities & alternative investments 822 691 685
818 708 Metals (including ClearPort) 265 184 215 190 201 --- ---
--- --- --- Total 13,145 10,331 10,311 10,349 10,132 Venue -----
Open outcry 1,811 1,456 1,338 1,431 1,264 Electronic 10,686 8,272
8,223 8,266 8,267 Privately negotiated 203 168 164 173 147 --- ---
--- --- --- Exchange-traded Total 12,700 9,895 9,726 9,871 9,679
CME ClearPort 445 436 586 478 453 --- --- --- --- --- Total 13,145
10,331 10,311 10,349 10,132 Average Rate Per Contract (RPC) CME
Group RPC (Legacy CME, CBOT, NYMEX and COMEX combined) Product Line
3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009 ------------ -------
------- ------- ------- ------- Interest rates $0.521 $0.569 $0.532
$0.525 $0.505 Equities 0.720 0.748 0.716 0.712 0.722 Foreign
exchange 0.936 0.894 0.918 0.901 0.853 Energy (including ClearPort)
1.629 1.773 1.608 1.653 1.694 Commodities & alternative
investments 1.154 1.154 1.108 1.130 1.199 Metals (including
ClearPort) 1.762 1.879 1.858 1.808 1.849 ----- ----- ----- -----
----- Average RPC $0.790 $0.866 $0.839 $0.823 $0.834 Venue -----
Exchange-traded $0.743 $0.801 $0.777 $0.765 $0.765 CME ClearPort
2.139 2.352 1.874 2.031 2.304 Note: All CME Group volume and rate
per contract data is based upon pro forma results, including the
operations of CME Group and NYMEX as if they were combined for the
entire period reported. All data excludes our non- traditional
TRAKRS products, for which CME Group receives significantly lower
clearing fees than other CME Group products. Additionally, all data
excludes Swapstream and HuRLO products. Note: Average daily volume
and rate per contract figures for prior periods have been revised
due to standardizing NYMEX reporting conventions to follow CME
Group's treatment of post-trade transactions such as exercises,
assignments and deliveries. DATASOURCE: CME Group Inc. CONTACT:
Media, Anita Liskey, +1-312-466-4613, or William Parke,
+1-312-930-3467, ; or Investors, John Peschier, +1-312-930-8491,
http://cmegroup.mediaroom.com/, all of CME Group Inc. Web Site:
http://www.cmegroup.com/
Copyright
CME (NASDAQ:CME)
Historical Stock Chart
From Jun 2024 to Jul 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Jul 2023 to Jul 2024